Analgesic-muscle relaxant infusion in back pain therapy – technological and clinical aspects

Czech version

Authors: I. Murínová - ^{1 3}; A. Linhartová ^1,4; J. Muselík ⁵; J. Cihlo ^1,6; L. Dvířková ^1,7; J. Gregorová ⁸; K. Kroutilová ^1,9; K. Langmaierová ^1,3,10; L. Polášková ^1,2; J. Vedrová ^1,11; M. Vodička ^1,12
Authors‘ workplace: Pracovní skupina pro ředění a podávání léčiv, Česká odborná společnost klinické farmacie ČLS JEP ¹; Oddělení klinické farmacie, ÚVN – VFN, Praha ²; Ústav aplikované farmacie, Farmaceutická fakulta, MU, Brno ³; Oddělení klinické farmacie, Lékárna, Fakultní Thomayerova nemocnice, Praha ⁴; Ústav farmaceutické technologie, Farmaceutická fakulta, MU, Brno ⁵; Lékárna Multiscan Pharma, s. r. o. – oddělení přípravy cytostatik, Pardubice ⁶; Oddělení klinické farmacie, FN Plzeň-Bory ⁷; Oddělení klinické farmacie, FN Bulovka, Praha ⁸; Pracoviště klinické farmacie, Ústavní lékárna, MOÚ, Brno ⁹; Oddělení klinické farmacie, Krajská zdravotní, a. s. – pracoviště Teplice ¹⁰; Pracoviště klinické farmacie, Ústav hematologie a krevní transfuze, Praha ¹¹; Pracoviště klinické farmacie, Lékárna, Krajská nemocnice T. Bati, a. s., Zlín ¹²
Published in: Cesk Slov Neurol N 2021; 84(5): 465-471
Category: Original Paper
doi: https://doi.org/10.48095/cccsnn2021465

Overview

Aim: The aim was to clarify the constituents and the method of administration of analgesic-muscle relaxant infusions (AMIs) routinely used in clinical practice, to rationalise individual components in AMIs, and to evaluate the compatibility and stability of the most often used AMI components. Methods: In the form of a questionnaire survey, 15 randomly selected clinical departments were contacted to obtain an overview of the spectrum of AMIs used in the Czech Republic. The rationality of the composition of AMIs was evaluated based on an assessment of the pharmacological and pharmaceutical properties of the drugs and the evidence for their use in back pain therapy. Furthermore, a compatibility and stability study of the two most often used AMIs (mixture No. 1: trimecaine, metamizole, guaifenesin; mixture No. 2: trimecaine, metamizole, magnesium sulfate) was conducted. Results: A large number of different combinations of drugs was found to be used, most often from the group of analgesics, muscle relaxants, corticosteroids, and local anaesthetics. The composition of AMIs proved not to be always completely rational, both from a pharmacotherapeutic (efficacy, safety, evidence) and technological (compatibility, stability) point of view. The performed technological study then proved the compatibility and stability of the two most frequently used mixtures. Conclusions: The established use of AMIs has a number of significant shortcomings. Therefore, in most cases and for a variety of reasons, oral administration of drugs seems to be more appropriate for the treatment of back pain. Intravenous therapy could thus be reserved for specific situations.

Keywords:

infusion therapy – muscle relaxants – back pain – Analgesics – oral therapy – stability study

Sources

1. Ambler Z. Základy neurologie. Praha: Galén 2011.

2. Zdravotnická ročenka České republiky 2018. [online]. Dustupné z URL: https: //www.uzis.cz/res/f/008280/zdrroccz-2018.pdf.

3. Hakl M. Léčba bolesti: současné přístupy k léčbě bolesti a bolestivých syndromů. Praha: Mladá fronta 2019.

4. ČOSKF ČLS JEP, Pracovní skupina pro ředění a podávání léčiv. [online]. Dostupné z URL: https: //www.coskf.cz/spolecnost/pracovni-skupiny/pracovni-skupina-pro-redeni-a-podavani-leciv/.

5. Sarver J, Pryka R, Alexander K et al. Stability of magnesium sulfate in 0.9% sodium chloride and lactated ringers solutions. Int J Pharm Compd 1998; 5 (2): 385–388.

6. Solomon D. UpToDate, NSAIDs: Therapeutic use and variability of response in adults, Topic 7993 Version 23.0. [online]. Available from URL: https: //somepomed.org/articulos/contents/mobipreview.htm?19/50/20271? source=see_link.

7. Solomon D. UpToDate, NSAIDs: Pharmacology and mechanism of action, Topic 7989 Version 17.0. [online]. Available from URL: https: //www.uptodate.com/contents/nsaids-pharmacology-and-mechanism-of- action.

8. SÚKL. Databáze léků, Souhrnu údajů o přípravku. [online]. Dostupné z URL: http: //www.sukl.cz/modules/medication/search.php.

9. Vymazal T, Urbánek K. Léčba bolesti fixní kombinací orfenadrinu a diklofenaku. Klin Farmakol Farm 2018; 32 (3): 26–33.

10. UpToDate, orphenadrine: drug information, Lexicomp, Topic 9722 Version 259.0. [online]. Available from URL: https: //somepomed.org/articulos/contents/mobipreview.htm?30/57/31645?source=HISTORY.

11. van Tulder MW, Touray T, Furlan AD et al. Muscle relaxants for non-specific low-back pain. Cochrane Database Syst Rev 2003; 2003 (2): CD004252. doi: 10.1002/1465 1858.CD004252.

12. Qaseem A, Wilt T, McLean R et al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2017; 166 (7): 514–530. doi: 10.7326/M16-2367.

13. Knight L, Deyo A, Staiger O et al. UpToDate, Treatment of acute low back pain, Topic 7780 Version 55.0. [online]. Available from URL: https: //www.scribd.com/document/401441417/Treatment-of-Acute-Low-Back-Pain-UpToDate.

14. Chou R, Deyo R, Friedly J et al. Nonpharmacologic therapies for low back pain: a systematic review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 2017; 166 (7): 493–505. doi: 10.7326/M16-2459.

15. Friedman B, Holden L, Esses D et al. Parenteral corticosteroids for emergency department patients with non-radicular low back pain. J Emerg Med 2006; 31 (4): 365–370. doi: 10.1016/j.jemermed.2005.09. 023.

16. Eskin B, Shih R, Fiesseler F et al. Prednisone for emergency department low back pain: a randomized controlled trial. J Emerg Med 2014; 47 (1): 65–70. doi: 10.1016/j.jemermed.2014.02.010.

17. Levin K, Hsu P, Armon C. UpToDate, Acute lumbosacral radiculopathy: treatment and prognosis, Topic 5259 Version 31.0. [online]. Available from URL: https: //www.uptodate.com/contents/acute-lumbosacral-radiculopathy-treatment-and-prognosis.

18. Levin K. UpToDate, Lumbar spinal stenosis: Treatment and prognosis, Topic 7781 Version 13.0. [online]. Available from URL: https: //www.uptodate.com/contents/lumbar-spinal-stenosis-treatment-and- prognosis.

19. Chou R. UpToDate, Subacute and chronic low back pain: nonsurgical interventional treatment, Topic 7768 Version 38.0. [online]. Available from URL: https: //www.uptodate.com/contents/subacute-and-chronic-low-back-pain-nonsurgical-interventional-treatment.

20. Firouzian A, Alipour A, Dezfouli H et al. Does lidocaine as an adjuvant to morphine improve pain relief in patients presenting to the ED with acute renal colic? A double-blind, randomized controlled trial. Am J Emerg Med 2016; 34 (3): 443–448. doi: 10.1016/j.ajem.2015.11.062.

21. Loj E, Scherber K, Cabrera D et al. Safety and efficacy of intravenous lidocaine for pain management in the emergency department: a systematic review. Ann Emerg Med 2018; 72 (2): 135–144.e3. doi: 10.1016/j.annemergmed.2017.12.014.

22. Tanen D, Shimada M, Danish D et al. Intravenous lidocaine for the emergency department treatment of acute radicular low back pain, a randomized controlled trial. J Emerg Med 2014; 47 (1): 119–124. doi: 10.1016/j.jemermed.2012.12.014.

23. Giorgi M, Łebkowska-Wieruszewska B, Lisowski A et al. Pharmacokinetic profiles of the active metamizole metabolites after four different routes of administration in healthy dogs. J vet Pharmacol Therap 2018; 41: 428–436. doi: 10.1111/jvp.12484.